(Q43686203)

25 November 2017

title

Anti-eosinophil activity and clinical efficacy of the CRTH2 antagonist OC000459 in eosinophilic esophagitis (English)

1 reference

25 November 2017

11

1 reference

25 November 2017

A Straumann

1

1 reference

25 November 2017

S Hoesli

2

1 reference

25 November 2017

Ch Bussmann

3

1 reference

25 November 2017

M Stuck

4

1 reference

25 November 2017

M Perkins

5

1 reference

25 November 2017

L P Collins

6

1 reference

25 November 2017

M Payton

7

1 reference

25 November 2017

R Pettipher

8

1 reference

25 November 2017

M Hunter

9

1 reference

25 November 2017

J Steiner

10

1 reference

25 November 2017

publication date

5 February 2013

1 reference

25 November 2017

1 reference

25 November 2017

volume

68

1 reference

25 November 2017

issue

3

1 reference

25 November 2017

page(s)

375-385

1 reference

Cytokine expression in normal and inflamed esophageal mucosa: a study into the pathogenesis of allergic eosinophilic esophagitis.

25 November 2017

cites work

1 reference

Eosinophilic esophagitis in children and adults: a systematic review and consensus recommendations for diagnosis and treatment

21 January 2018

1 reference

Eosinophilic esophagitis: updated consensus recommendations for children and adults

21 January 2018

1 reference

Diagnosis and management of eosinophilic esophagitis

21 January 2018

1 reference

Epidemiology of eosinophilic esophagitis over three decades in Olmsted County, Minnesota

21 January 2018

1 reference

Identification, epidemiology, and chronicity of pediatric esophageal eosinophilia, 1982-1999.

21 January 2018

1 reference

Prevalence of oesophageal eosinophils and eosinophilic oesophagitis in adults: the population-based Kalixanda study

21 January 2018

1 reference

Pediatric and adult eosinophilic esophagitis: similarities and differences

21 January 2018

1 reference

Eosinophilic esophagitis: analysis of food impaction and perforation in 251 adolescent and adult patients

21 January 2018

1 reference

Esophageal remodeling develops as a consequence of tissue specific IL-5-induced eosinophilia

21 January 2018

1 reference

Resolution of remodeling in eosinophilic esophagitis correlates with epithelial response to topical corticosteroids

21 January 2018

1 reference

Subepithelial collagen deposition, profibrogenic cytokine gene expression, and changes after prolonged fluticasone propionate treatment in adult eosinophilic esophagitis: a prospective study.

21 January 2018

1 reference

Comparison of oral prednisone and topical fluticasone in the treatment of eosinophilic esophagitis: a randomized trial in children

21 January 2018

1 reference

Eosinophilic esophagitis in children: immunopathological analysis and response to fluticasone propionate

21 January 2018

1 reference

Topical corticosteroid treatment of dysphagia due to eosinophilic esophagitis in adults

21 January 2018

1 reference

A randomized, double-blind, placebo-controlled trial of fluticasone propionate for pediatric eosinophilic esophagitis.

21 January 2018

1 reference

Oral viscous budesonide is effective in children with eosinophilic esophagitis in a randomized, placebo-controlled trial

21 January 2018

1 reference

Budesonide is effective in adolescent and adult patients with active eosinophilic esophagitis

21 January 2018

1 reference

Comparison of esomeprazole to aerosolized, swallowed fluticasone for eosinophilic esophagitis.

21 January 2018

1 reference

An antibody against IL-5 reduces numbers of esophageal intraepithelial eosinophils in children with eosinophilic esophagitis.

21 January 2018

1 reference

Reslizumab in children and adolescents with eosinophilic esophagitis: results of a double-blind, randomized, placebo-controlled trial.

21 January 2018

1 reference

Antagonism of the prostaglandin D2 receptors DP1 and CRTH2 as an approach to treat allergic diseases

21 January 2018

1 reference

Prostaglandin D2 induces the production of human beta-defensin-3 in human keratinocytes

21 January 2018

1 reference

Pharmacologic profile of OC000459, a potent, selective, and orally active D prostanoid receptor 2 antagonist that inhibits mast cell-dependent activation of T helper 2 lymphocytes and eosinophils

21 January 2018

1 reference

A randomized, double-blind, placebo-controlled study of the CRTH2 antagonist OC000459 in moderate persistent asthma

21 January 2018

1 reference

Histopathologic variability and endoscopic correlates in adults with eosinophilic esophagitis.

21 January 2018

1 reference

Eosinophilic esophagitis: asthma of the esophagus?

21 January 2018

1 reference

Sensing the outside world: TSLP regulates barrier immunity.

21 January 2018

1 reference

Escalating incidence of eosinophilic esophagitis: A 20-year prospective, population-based study in Olten County, Switzerland

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1111/ALL.12096

1 reference

25 November 2017

1 reference